<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Goga A</submitter><funding>Wellcome Trust</funding><pagination>04009</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12856961</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Knowledge gaps persist regarding paediatric COVID-19 clinical presentation, treatment and outcomes in high HIV prevalence settings, with low COVID-19 vaccine coverage.&lt;h4>Methods&lt;/h4>An ambi-directional cohort study was conducted in 13 South African public sector hospitals. Hospitalised children with SARS-CoV-2 infection or post-infection syndrome were included. Main outcomes measures included severe disease and primary COVID-19 (hospitalisation for SARS-CoV-2 infection).&lt;h4>Results&lt;/h4>There were 2363 SARS-CoV-2 positive children included (March 2020 through May 2023); median age 23.6 months (interquartile range (IQR) = 4.3-98.2 months). Excluding missing values, 1618 (68.9%) children had primary COVID-19; 1121 (69.3%) of these had severe primary COVID-19. In the primar</pubmed_abstract><journal>Journal of global health</journal><pubmed_title>Severe, primary, and incidental COVID-19 in hospitalised children, South Africa: 2020-2023.</pubmed_title><pmcid>PMC12856961</pmcid><funding_grant_id>221372/Z/20/Z</funding_grant_id><pubmed_authors>Ramraj T</pubmed_authors><pubmed_authors>Waggie Z</pubmed_authors><pubmed_authors>Donald KA</pubmed_authors><pubmed_authors>Chetty T</pubmed_authors><pubmed_authors>Cloete J</pubmed_authors><pubmed_authors>Scott C</pubmed_authors><pubmed_authors>Van Zyl R</pubmed_authors><pubmed_authors>Chinniah K</pubmed_authors><pubmed_authors>Mawela D</pubmed_authors><pubmed_authors>Cawood S</pubmed_authors><pubmed_authors>Dangor Z</pubmed_authors><pubmed_authors>Reubenson G</pubmed_authors><pubmed_authors>Morrow BM</pubmed_authors><pubmed_authors>Strehlau R</pubmed_authors><pubmed_authors>Zuhlke L</pubmed_authors><pubmed_authors>Feucht U</pubmed_authors><pubmed_authors>Tabane NE</pubmed_authors><pubmed_authors>du Plessis NM</pubmed_authors><pubmed_authors>Moore DP</pubmed_authors><pubmed_authors>Aldersley T</pubmed_authors><pubmed_authors>Jeena P</pubmed_authors><pubmed_authors>Mchunu N</pubmed_authors><pubmed_authors>Zar HJ</pubmed_authors><pubmed_authors>Webb K</pubmed_authors><pubmed_authors>Archary M</pubmed_authors><pubmed_authors>Reddy T</pubmed_authors><pubmed_authors>Velaphi S</pubmed_authors><pubmed_authors>Goga A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Severe, primary, and incidental COVID-19 in hospitalised children, South Africa: 2020-2023.</name><description>&lt;h4>Background&lt;/h4>Knowledge gaps persist regarding paediatric COVID-19 clinical presentation, treatment and outcomes in high HIV prevalence settings, with low COVID-19 vaccine coverage.&lt;h4>Methods&lt;/h4>An ambi-directional cohort study was conducted in 13 South African public sector hospitals. Hospitalised children with SARS-CoV-2 infection or post-infection syndrome were included. Main outcomes measures included severe disease and primary COVID-19 (hospitalisation for SARS-CoV-2 infection).&lt;h4>Results&lt;/h4>There were 2363 SARS-CoV-2 positive children included (March 2020 through May 2023); median age 23.6 months (interquartile range (IQR) = 4.3-98.2 months). Excluding missing values, 1618 (68.9%) children had primary COVID-19; 1121 (69.3%) of these had severe primary COVID-19. In the primar</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T06:47:40.725Z</modification><creation>2026-07-09T10:42:18.313Z</creation></dates><accession>S-EPMC12856961</accession><cross_references><pubmed>41614559</pubmed><doi>10.7189/jogh.16.04009</doi></cross_references></HashMap>